Authors
Alexandre Tran, Robert Talarico, Tzu-Fei Wang, Celine Girard, Deborah Siegal, Kednapa Thavorn, Kevin Durr, Shannon M Fernando, Bram Rochwerg, Rebecca Mathew, Rakesh Patel, Leah Rosenkrantz, Marc Carrier
Published in
Annals of the American Thoracic Society. Jul 28, 2026. Epub Jul 28, 2026.
Abstract
Venous thromboembolism (VTE) remains an important complication of critical illness, but contemporary population-level estimates of clinically recognized VTE and ICU-associated risk are limited.
To quantify 90-day VTE incidence in ICU vs non-ICU hospitalizations, estimate the adjusted association between ICU exposure and VTE, and identify factors associated with VTE within the ICU cohort.
We conducted a population-based cohort study using linked health administrative data in Ontario, Canada (ICES). We included patients aged ≥16 years and randomly selected one hospitalization per patient. ICU exposure was identified using discharge abstract special care unit codes. Clinically recognized VTE within 90 days was identified using ICD-10-CA diagnosis codes with confirmatory imaging/procedure codes in the same encounter or within ±7 days. We estimated cumulative incidence with death as a competing risk and fit cause-specific Cox models to estimate adjusted hazard ratios (aHRs), including an ICU-restricted model with ICU therapies and ICU length-of-stay.
Among 4,821,130 index hospitalizations, 575,155 (11.9%) had ICU exposure. Ninety-day VTE occurred in 43,913 (0.9%) overall and was higher in ICU vs non-ICU hospitalizations (1.6% vs 0.8%; Gray's test P < 0.001). Hospitalizations involving ICU exposure were associated with higher VTE hazard after adjustment (aHR 1.38, 95% CI 1.34-1.43). In the ICU cohort, higher VTE risk was associated with prior VTE, cancer, recent surgery, prolonged ICU stay, extracorporeal membrane oxygenation, and traumatic brain injury.
Hospitalizations involving ICU exposure were associated with higher 90-day clinically recognized VTE risk, and risk was concentrated in identifiable high-risk ICU subgroups, supporting risk stratification and risk-enriched future studies.
PMID:
42518211
Bibliographic data and abstract were imported from PubMed on 28 Jul 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 6
- Comments 0